单侧甲状腺乳头状癌对侧中央区淋巴结转移的相关危险因素分析

Abstract
Figure/Table
References (22)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the risk factors of contralateral central lymph nodes(Cont-CLNs)metastasis in unilateral papillary thyroid carcinoma(uPTC).Methods The clinical data were collected from the uPTC patients who had underwent total thyroidectomy and bilateral central lymphadenectomy in Suining City Central Hospital from January 2014 to August 2020,and were analyzed retrospectively.And the risk factors related to Cont-CLNs were analyzed.Results A total of 119 eligible patients were collected,the rate of Cont-CLNs metastasis was 26.89%(32/119).The univariate analysis showed that Cont-CLNs metastasis was related to the Ipsi-CLNs metastasis,gender,diseased glandular lobe,tumor size,the distance between the lower edge of tumor and the lower edge of thyroid and Hashimoto's thyroiditis(P＜0.05).The result of Logistic regression model revealed that Ipsi-CLNs metastasis，the distance between the lower edge of tumor and the lower edge of thyroid≤10 mm and male were independent risk factors of Cont-CLNs metastasis(P＜0.05).Conclusion Cont-CLNs dissection should be considered when unilateral thyroid papillary carcinoma is associated with high-risk features such as Ipsi-CLNs metastasis,the distance between the lower edge of tumor and the lower edge of thyroid≤10 mm and male.

Key words： Unilateral papillary thyroid carcinoma Contralateral central lymph node dissection Contralateral central lymph node metastasis Risk factors

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MU De-wu
	CHEN Mao-shan
	FAN Li
	DU Song-li
	YANG Hong-wei

Cite this article:

MU De-wu,CHEN Mao-shan,FAN Li, et al. Analysis of the risk factors of contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma[J]. 中国当代医药, 2021, 28(14): 95-98转102.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I14/95

[1]	Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin，2018，68（6）：394-424.
[2]	Ryu YJ，Kang SJ，Cho JS，et al.Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer[J].Medicine（Baltimore），2018，97（51）：e13435.
[3]	王伟斌，苏星韵，阮佳莹，等.2682例甲状腺乳头状癌临床病理及预后分析[J].中华普通外科杂志，2018，33（5）：393-397.
[4]	高明.甲状腺结节和分化型甲状腺癌诊治指南[J].中国肿瘤临床，2012，39（17）：1249-1272.
[5]	宋强，袁海清，宋晓彪.对比分析预防性颈中央区淋巴结清扫术，传统甲状腺全切除术治疗甲状腺癌的应用效果[J].临床医药文献电子杂志，2020，7（21）：56.
[6]	Giordano D，Valcavi R，Thompson GB，et al.Complications of Central Neck Dissection in Patients with Papillary Thyroid Carcinoma：Results of a Study on 1087 Patients and Review of the Literature[J].Thyroid，2012，22（9）：911-917.
[7]	李东，严卫忠，谢华，等.单侧分化型甲状腺癌行双侧中央区淋巴结清扫的临床研究[J].承德医学院学报，2019，36（4）：285-287.
[8]	严卫忠，李东，谢华，等.双侧中央区淋巴结清扫在单侧分化型甲状腺癌治疗中的意义[J].癌症进展，2020，18（10）：1054-1056.
[9]	Yan B，Hou Y，Chen D，et al.Risk factors for contralateral central lymph node metastasis in unilateral cN0 papillary thyroid carcinoma：A meta-analysis[J].Int J Surg，2018，59：90-98.
[10]	Bohec H，Breuskin I，Hadoux J，et al.Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma[J].World J Surg，2019，43（3）：818-823.
[11]	Jeon MJ，Yoon JH，Han J M，et al.The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma[J].Eur J Endocrinol，2013，168（2）：219-225.
[12]	Attard A，Paladino NC，Monte AIL，et al.Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer：a systematic review[J].BMC Surg，2019，18（S1）：112.
[13]	Lei J，Zhong J，Jiang K，et al.Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma[J].Oncotarget，2017，8（16）：27 022-27 033.
[14]	严淑萍，杨敬，龚艳萍，等.单发甲状腺微小乳头状癌对侧中央区淋巴结转移的危险因素[J].四川大学学报（医学版），2016，47（1）：81-84.
[15]	Kim SK，Park I，Hur N，et al.Patterns，Predictive Factors，and Prognostic Impact of Contralateral Lateral Lymph Node Metastasis in N1b Papillary Thyroid Carcinoma[J].Ann Surg Oncol，2017，24（7）：1943-1950.
[17]	丁金旺，彭友，张卧，等.单侧甲状腺乳头状癌对侧中央区淋巴结转移的临床危险因素分析[J].中国耳鼻咽喉头颈外科，2018，25（8）：406-410.
[20]	张红梅，吴波，刘芮，等.单侧非微小甲状腺乳头状癌双侧中央区淋巴结清扫的临床意义[J].实用医院临床杂志，2019，16（5）：129-132.
[22]	周静，胡代星，苏新良，等.cN0单侧甲状腺乳头状癌中央区各亚区与患侧侧区淋巴结转移关系的探讨[J].中华内分泌外科杂志，2019，13（1）：31-35.
[16]	Yu W，Xu G，Sun J，et al.Carbon nanoparticles guide contralateral central neck dissection in patients with papillary thyroid cancer[J].Oncol Lett，2018，16（1）：447-452.
[18]	Wei T，Chen R，Zou X，et al.Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma[J].Eur J Surg Oncol，2015，41（6）：746-750.
[19]	Kim SY，Seok-Mo Kim，Chang H，et al.Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe[J].ANZ J Surg，2019，89（11）：E498-E501.
[21]	Liu W，Cheng R，Su Y，et al.Risk factors of central lymph node metastasis of papillary thyroid carcinoma：A singlecenter retrospective analysis of 3273 cases[J].Medicine（Baltimore），2017，96（43）：e8365.